These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 29709013

  • 41. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
    Atencio P, Cabello A, Conesa-Buendía FM, Pérez-Tanoira R, Prieto-Pérez L, Carrillo I, Álvarez B, Arboiro-Pinel R, Díaz-Curiel M, Herrero-Beaumont G, Mediero A, Górgolas M.
    BMC Infect Dis; 2021 Jun 09; 21(1):542. PubMed ID: 34107907
    [Abstract] [Full Text] [Related]

  • 42. Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.
    Puthanakit T, Saksawad R, Bunupuradah T, Wittawatmongkol O, Chuanjaroen T, Ubolyam S, Chaiwatanarat T, Nakavachara P, Maleesatharn A, Chokephaibulkit K.
    J Acquir Immune Defic Syndr; 2012 Dec 01; 61(4):477-83. PubMed ID: 22918157
    [Abstract] [Full Text] [Related]

  • 43. Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.
    Bolland MJ, Horne AM, Briggs SE, Thomas MG, Reid IR, Gamble GD, Grey A.
    Calcif Tissue Int; 2019 Oct 01; 105(4):423-429. PubMed ID: 31250043
    [Abstract] [Full Text] [Related]

  • 44. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.
    Tomazic J, Ul K, Volcansek G, Gorensek S, Pfeifer M, Karner P, Prezelj J, Vidmar G, Vidmar L.
    Wien Klin Wochenschr; 2007 Oct 01; 119(21-22):639-46. PubMed ID: 18043884
    [Abstract] [Full Text] [Related]

  • 45. Low bone mineral density in HIV-positive young Italians and migrants.
    Cascio A, Colomba C, Di Carlo P, Serra N, Lo Re G, Gambino A, Lo Casto A, Guglielmi G, Veronese N, Lagalla R, Sergi C.
    PLoS One; 2020 Oct 01; 15(9):e0237984. PubMed ID: 32881882
    [Abstract] [Full Text] [Related]

  • 46. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
    Schtscherbyna A, Pinheiro MF, Mendonça LM, Gouveia C, Luiz RR, Machado ES, Farias ML.
    Int J Infect Dis; 2012 Dec 01; 16(12):e872-8. PubMed ID: 23031418
    [Abstract] [Full Text] [Related]

  • 47. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    Bregigeon S, Galinier A, Zaegel-Faucher O, Cano CE, Obry V, Laroche H, Trijau S, Saout A, Poizot-Martin I.
    AIDS; 2017 Jul 17; 31(11):1573-1577. PubMed ID: 28426535
    [Abstract] [Full Text] [Related]

  • 48. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E, Ursini T, Agostinone A, Di Nicola AD, Polilli E, Sozio F, Vadini F, Pieri A, Trave F, De Francesco V, Capasso L, Borderi M, Manzoli L, Viale P, Parruti G.
    AIDS Patient Care STDS; 2015 Apr 17; 29(4):169-80. PubMed ID: 25692868
    [Abstract] [Full Text] [Related]

  • 49. Longitudinal change in bone mineral density among Chinese individuals with HIV after initiation of antiretroviral therapy.
    Guo F, Song X, Li Y, Guan W, Pan W, Yu W, Li T, Hsieh E.
    Osteoporos Int; 2021 Feb 17; 32(2):321-332. PubMed ID: 32803316
    [Abstract] [Full Text] [Related]

  • 50. Hypovitaminosis D and hyperparathyroidism: effects on bone turnover and bone mineral density among perinatally HIV-infected adolescents.
    Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Ananworanich J, Puthanakit T, Bone-D Study Group.
    AIDS; 2016 Apr 24; 30(7):1059-67. PubMed ID: 26807972
    [Abstract] [Full Text] [Related]

  • 51. Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.
    Erlandson KM, Lake JE, Sim M, Falutz J, Prado CM, Domingues da Silva AR, Brown TT, Guaraldi G.
    J Acquir Immune Defic Syndr; 2018 Mar 01; 77(3):288-294. PubMed ID: 29140875
    [Abstract] [Full Text] [Related]

  • 52. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK, Huang M, Prasad GV.
    J Nephrol; 2012 Mar 01; 25(3):373-83. PubMed ID: 21928224
    [Abstract] [Full Text] [Related]

  • 53. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep 01; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 54. Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine.
    Kim HS, Chin BS, Shin HS.
    J Korean Med Sci; 2013 Jun 01; 28(6):827-32. PubMed ID: 23772145
    [Abstract] [Full Text] [Related]

  • 55. [Influence of long-term highly active antiretroviral therapy on bone mineral density in HIV/AIDS patients].
    Su YB, Xie J, Han Y, Qiu ZF, Li YL, Song XJ, Yu W, Li TS.
    Zhonghua Yi Xue Za Zhi; 2012 May 08; 92(17):1155-8. PubMed ID: 22883000
    [Abstract] [Full Text] [Related]

  • 56. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.
    Neth J Med; 2017 May 08; 75(4):138-144. PubMed ID: 28522769
    [Abstract] [Full Text] [Related]

  • 57. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
    Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A.
    J Infect Dis; 2009 Dec 01; 200(11):1746-54. PubMed ID: 19874178
    [Abstract] [Full Text] [Related]

  • 58. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA, Karaosmanoglu HK, Karahasanoglu R, Tahmaz M, Nazlıcan O.
    Braz J Infect Dis; 2013 Dec 01; 17(6):707-11. PubMed ID: 24076108
    [Abstract] [Full Text] [Related]

  • 59. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
    Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA.
    HIV Clin Trials; 2003 Dec 01; 4(5):337-46. PubMed ID: 14583850
    [Abstract] [Full Text] [Related]

  • 60. Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy.
    Crespo M, Navarro J, Martinez-Rebollar M, Podzamczer D, Domingo P, Mallolas J, Saumoy M, Mateo GM, Curran A, Gatell J, Ribera E.
    HIV Clin Trials; 2016 May 01; 17(3):89-95. PubMed ID: 27125363
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.